Noratis AG
XETRA:NUVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Noratis AG
XETRA:NUVA
|
DE |
|
Lippo General Insurance Tbk PT
IDX:LPGI
|
ID |
|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
IL |
|
A
|
Advanced Biomed Inc
NASDAQ:ADVB
|
US |
|
Nihon M&A Center Holdings Inc
TSE:2127
|
JP |
|
N
|
Ningbo Sunrise Elc Technology Co Ltd
SZSE:002937
|
CN |
|
Eco Depot Inc
OTC:ECDP
|
US |
Wall Street
Price Targets
NUVA Price Targets Summary
Noratis AG
According to Wall Street analysts, the average 1-year price target for
NUVA
is 1.122 EUR
with a low forecast of 1.111 EUR and a high forecast of 1.155 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NUVA's stock price target?
Price Target
1.122
EUR
According to Wall Street analysts, the average 1-year price target for
NUVA
is 1.122 EUR
with a low forecast of 1.111 EUR and a high forecast of 1.155 EUR.
What is Noratis AG's Revenue forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Noratis AG's revenue is
5%.
The projected
CAGR
for the next 4 years is
5%.
What is Noratis AG's Operating Income forecast?
Projected CAGR
24%
For the last 8 years the
compound annual growth rate for
Noratis AG's operating income is
-19%.
The projected
CAGR
for the next 4 years is
24%.
